Accueil > La Médiathèque > Dossiers > Cellules souches et médecine régénérative > Références

Enregistrer au format PDF

Cellules souches et médecine régénérative

Références

Les références sont classées par date de mise en ligne. Les URL ont été vérifiées en juin 2014. En cas de problème, il est généralement possible de récupérer le document avec un moteur de recherche en faisant une requête avec le titre.

1995-12-08 [1] Eric F. WIESCHAUS. From Molecular Patterns to Morphogenesis : The Lessons from Drosophila. Nobel Lecture.

2000-02-24 [2] Alain CLAEYS, Claude HURIET. Rapport sur le clonage le clonage, la thérapie cellulaire et l’utilisation thérapeutique des cellules embryonnaires. Assemblée nationale : n° 2198 (11ème législature) - Sénat : n° 238 (1999-2000).

2001-07-16 [3] Stem Cells : Scientific Progress and Future Research Directions. Department of Health and Human Services.

2004-03-16 [4] Aspects éthiques des banques de sang de cordon ombilical. Avis du Groupe européen d’éthique des sciences et des nouvelles technologies auprès de la Commission européenne.

2006-02-23 [5] Inside the Cell. National Institutes of Health.

2006-06-12 [6] Umbilical Cord Blood Banking – Scientific Advisory Committee Opinion Paper 2. Royal College of Obstetricians and Gynaecologists.

2006-08-21 [7] Regenerative Medicine. Department of Health and Human Services.

2006-11-14 [8] Xianwen HU, Qingjun MA, Shuyong ZHANG. Biopharmaceuticals in China. Biotechnology Journal, 1 (2006) 1215–1224.

2007-06-26 [9] Parliamentary questions : Answer given by Mr Potočnik on behalf of the Commission. E-1384/2007. Commission européenne.

2007-11-15 [10] François LEMAIRE. Les 60 ans du procès des médecins de Nuremberg - Pourquoi le Code n’a-t-il pas été appliqué avant plusieurs décennies ? médecine/sciences, 23 (2007) 1063-1067.

2007-12-07 [11] Avis aux demandeurs d’Autorisation Temporaire d’Utilisation (ATU). Agence nationale de sécurité du médicament et des produits de santé (ANSM).

2008-05-22 [12] Dois-je conserver le sang de cordon ombilical de mon bébé au cas où il / elle en a besoin plus tard dans sa vie ? EuroStemCell.

2009-12-15 [13] Dominique S McMAHON, Halla THORSTEINSDÓTTIR, Peter A SINGER, Abdallah S DAAR. Cultivating regenerative medicine innovation in China. Regenerative Medicine, 5 (2010) 35–44.
2010-02-09 [14] Cellules souches de la peau : où se trouvent-elles et que peuvent-elles faire ? EuroStemCell.

2010-03-23 [15] Cancer : Une maladie des cellules souche ? EuroStemCell.

2010-07-19 [16] Nicholas J. LEEPER, Arwen L. HUNTER, John P. COOKE. Stem Cell Therapy for Vascular Regeneration : Adult, Embryonic, and Induced Pluripotent Stem Cells. Circulation, 122 (2010) 517-526.

2011-03-08 [17] Abhishek SOHNI, Catherine M. VERFAILLIE. Multipotent adult progenitor cells. Best Practice & Research Clinical Haematology, 24 (2011) 3–11.

2011-04-20 [18] Cellules souches sanguines : les pionnières de la recherche sur les cellules souches. EuroStemCell.

2011-09-05 [19] Rosario ISASI, Bartha M. KNOPPERS. From Banking to International Governance : Fostering Innovation in Stem Cell Research. Stem Cells International, (2011).

2011-09-28 [20] Heidi LEDFORD. Translational research : 4 ways to fix the clinical trial. Nature, 477 (2011) 526-528.

2011-10-18 [21] Arrêt de la Cour (grande chambre) du 18 octobre 2011. Affaire C-34/10 Oliver Brüstle contre Greenpeace eV. Cour de justice de l’Union européenne.

2011-11-15 [22] Jef AKST. First hESC Trial Kaput. The Scientist. http://www.the-scientist.com/?articles.view/articleNo/31391/title/First-hESC-Trial-Kaput/
2011-12-12 [23] Charles KESSLER. EU Support to Stem Cell Research. Research and Innovation DG. European Commission.

2012-02-22 [24] Andre F. STEINERT, Lars RACKWITZ, Fabian GILBERT, Ulrich NÖTH, Rocky S. TUAN. Concise Review : The Clinical Application of Mesenchymal Stem Cells for Musculoskeletal Regeneration : Current Status and Perspectives. Stem Cells Translational Medicine, 1 (2012) 237–247.

2012-03-09 [25] Avik S. A. ROY. Stifling New Cures : The True Cost of Lengthy Clinical Drug Trials. Project FDA No. 5. Manhattan Institute for Policy Research, Inc.

2012-04-03 [26] L’œil et les cellules souches : vers le traitement de la cécité. EuroStemCell.

2012-04-20 [27] Jocelyn KAISER. Texas Medical Board Approves Rules for Controversial Treatment. Science, 336 (2012) 284.

2012-05-08 [28] Srinivasan N. KELLATHUR, Huei-Xin LOU. Cell and tissue therapy regulation : Worldwide status and harmonization. The International Alliance for Biological Standardization. Biologicals, 40 (2012) 222-224.

2012-05-11 [29] Malorye ALLISON. Reinventing clinical trials. Nature Biotechnology, 30 (2012) 41-49.

2012-06-14 [30] Cédric BLANPAIN, George Q. DALEY, Konrad HOCHEDLINGER, Emmanuelle PASSEGUÉ, Janet ROSSANT, Shinya YAMANAKA. Stem cells assessed. Nature Reviews Molecular Cell Biology, 13 (2012) 471-476.

2012-06-14 [31] Shinya YAMANAKA. Induced Pluripotent Stem Cells : Past, Present, and Future. Cell Stem Cell, 10 (2012) 678-684.

2012-06-20 [32] Les cellules souches mésenchymateuses : les “autres” cellules souches de moelle osseuse. EuroStemCell.

2012-08 [33] Learn About Clinical Studies. ClinicalTrials.gov.

2012-08-09 [34] David CYRANOSKI. Stem-cell pioneer banks on future therapies. Nature, 488 (2012) 139.

2012-08-11 [35] Johnson RAJASINGH. Reprogramming of Somatic Cells. Progress in Molecular Biology and Translational Science, 111 (2012) 51-82.

2012-10-02 [36] Peter LÖSER, Sabine KOBOLD, Anke GUHR, Franz-Josef MÜLLER, Andreas KURTZ. Scope and Impact of International Research in Human Pluripotent Stem Cells. Stem Cell Reviews and Reports, 8 (2012) 1048–1055.

2012-10-11 [37] Milena BELLIN, Maria C. MARCHETTO, Fred H. GAGE, Christine L. MUMMERY. Induced pluripotent stem cells : the new patient ? Nature Reviews Molecular Cell Biology, 13 (2012) 713-726.

2012-12-07 [38] Sir John B. GURDON. The Egg and the Nucleus : A Battle for Supremacy. Nobel Lecture.

2012-12-07 [39] Shinya YAMANAKA. The Winding Road to Pluripotency. Nobel Lecture.

2012-12-07 [40] Douglas SIPP, Leigh TURNER. U.S. Regulation of Stem Cells as Medical Products. Science, 338 (2012) 1296-1297.

2012-12-07 [41] Chris MASON, Mark J. McCALL, Emily J. CULME-SEYMOUR, Shalini SUTHASAN, Simon EDWARDS-PARTON, Gregory A. BONFIGLIO, Brock C. REEVE. The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012. Cell Stem Cell, 11 (2012) 735-739.

2012-12-19 [42] Cellules souches de cordon ombilical : applications actuelles et défis futurs.
EuroStemCell.

2013-01 [43] Hématopoïèse, cellules souches hématopoïétiques, facteurs de croissance. Laboratoire d’Hématologie Cellulaire du CHU d’Angers.

2013-01-08 [44] Products regulated as biologicals. Therapeutic Goods Administration, Australia.

2013-01-24 [45] David CYRANOSKI. Japan’s stimulus package showers science with cash. Nature, 493 (2013) 465.

2013-02-14 [46] David CYRANOSKI. Stem cells in Texas : Cowboy culture. Nature, 494 (2013) 166-168.

2013-03-05 [47] Robert H. AICHER, Esq. Is the FDA Regulating the Practice of Medicine ? Aesthetic Surgery Journal, 33 (2013) 452-455.

2013-04-03 [48] Cellules souches du tissu adipeux – Sécurité et qualité pour la médicine esthétique. SSCB - Swiss Stem Cell Bank.

2013-04-16 [49] Biotechnology in China - Q&A. IHEST.

2013-04-16 [50] The Pharmaceutical Industry and China – Q&A. IHEST. http://www.ihest.fr/international-edition/multimedia-library/the-pharmaceutical-industry-and

2013-04-25 [51] David CYRANOSKI. Japan to offer fast-track approval path for stem cell therapies. Nature, 19 (2013) 510.

2013-05-13 [52] Patrick CAHAN, George Q. DALEY. Origins and implications of pluripotent stem cell variability and heterogeneity. Nature Reviews Molecular Cell Biology, 14 (2013) 357-368.

2013-05-15 [53] M. DHANASEKARAN, S. INDUMATHI, R. POOJITHA, A. KANMANI, J. S. RAJKUMAR, D. SUDARSANAM. Plasticity and banking potential of cultured adipose tissue derived mesenchymal stem cells. Cell and Tissue Banking, 14 (2013] 303-315.

2013-05-22 [54] Bridget M. DEASY, Jordan E. ANDERSON, Shannon ZELINA. Regulatory Issues in the Therapeutic Use of Stem Cells. In Regenerative Medicine and Tissue Engineering, Jose A. ANDRADES edit. ISBN 978-953-51-1108-5.

2013-05-30 [55] M. William LENSCH, Christine L. MUMMERY. From Stealing Fire to Cellular Reprogramming : A Scientific History Leading to the 2012 Nobel Prize. Stem Cell Reports, 1 (2013) 5–17.

2013-06-12 [56] Maurizio BIFULCO, Patrizia GAZZERRO. The right to care and the expectations of society – controversial stem cell therapy in Italy. EMBO reports, 14 (2013) 578.

2013-06-18 [57] Carte des ressources canadiennes dans le domaine des cellules souches et de la médecine régénératrice : survol des travaux de recherche sur les cellules souches et la médecine régénérative au Canada. Ministère de l’industrie du Canada.

2013-07-01 [58] Regenerative medicine. Science and Technology Committee - First Report. House of Lords.

2013-07-12 [59] Allen M. SPIEGEL. The Stem Cell Wars : A Dispatch from the Front. Transactions of the American Clinical and Climatological Association, 124 (2013)

2013-08-06 [60] Rapport annuel 2012 de l’Agence de la biomedicine.

2013-08-07 [61] Loi n° 2013-715 du 6 août 2013 tendant à modifier la loi no 2011-814 du 7 juillet 2011 relative à la bioéthique en autorisant sous certaines conditions la recherche sur l’embryon et les cellules souches embryonnaires.

2013-08-19 [62] Cameron L STEWART, Lorena C APARICIO, Ian H KERRIDGE. Ethical and legal issues raised by cord blood banking — the challenges of the new bioeconomy. The Medical Journal of Australia, 199 (2013) 290-292.

2013-09-09 [63] Alice BOMBOY. Les essais cliniques. Pourquoi sont-ils incontournables ? Science & Santé, 16 (2013) 22-33.

2013-10-09 [64] Agence de la biomédecine – Rapport d’information au Parlement et au Gouvernement – septembre 2013.

2013-10-09 [65] Paolo BIANCO, Roger BARKER, Oliver BRÜSTLE, Elena CATTANEO, Hans CLEVERS, George Q DALEY, Michele DE LUCA, Lawrence GOLDSTEIN, Olle LINDVALL, Christine MUMMERY, Pamela G ROBEY, Clara SATTLER DE SOUSA E BRITO, Austin SMITH. Regulation of stem cell therapies under attack in Europe : for whom the bell tolls. The EMBO Journal, 32 (2013) 1489–1495.

2013-10-13 [66] Mahendra S RAO. LULL(ed) into complacency : a perspective on licenses and stem cell translational science. Stem Cell Research & Therapy, 4 (2013) 98

2013-10-14 [67] Le don, le prélèvement et la greffe de sang de cordon. Agence de la biomédecine.

2013-11-13 [68] Alessandro BLASIMME, Emmanuelle RIAL-SEBBAG. Regulation of Cell - Based Therapies in Europe : Current Challenges and Emerging Issues. Stem Cells and Development, 22 Supp. 1 (2013) 14-19.

2013-11-13 [69] Paul S. KNOEPFLER. Key Action Items for the Stem Cell Field : Looking Ahead to 2014. Stem Cells and Development, 22 Supp. 1 (2013) 10-12.

2013-11-18 [70] Qi ZHOU. Regulatory and Legal Frameworks for Offering Stem Cell Therapies in China. Stem Cell Therapies : Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings Workshop.

2013-11-18 [71] Toshio MIYATA. Regulatory and legal frameworks for offering stem cell therapies in Japan. Stem Cell Therapies : Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings Workshop.

2013-11-25 [72] Myrthe G NIELEN, Sybe A de VRIES, Niels GEIJSEN. European stem cell research in legal shackles. The EMBO Journal, 32 (2013) 3107–3111.

2013-12-04 [73] Nicholas A. ZACHARIADES. Stem Cells : Intellectual Property Issues in Regenerative Medicine. Stem Cells and Development, 22 Supp. 1 (2013) 59-62.

2013-12-04 [74] Sarah BURNINGHAM, Adam OLLENBERGER, Timothy CAULFIELD. Commercialization and Stem Cell Research : A Review of Emerging Issues. Stem Cells and Development, 22 Supp. 1 (2013) 80-84.

2013-12-06 [75] Matthew D LI, Harold ATKINS, Tania BUBELA. The global landscape of stem cell clinical trials. Regenerative Medicine, 9 (2014) 27–39.

2013-12-19 [76] Editorials. Stem-cell fiasco must be stopped. Nature, 504 (2013) 331.

2014-01-02 [77] Kevin G. CHEN, Barbara S. MALLON, Ronald D.G. McKAY, Pamela G. ROBEY. Human Pluripotent Stem Cell Culture : Considerations for Maintenance, Expansion, and Therapeutics. Cell Stem Cell, 14 (2014) 13-26.

2014-01-08 [78] Yaser ATLASI, Leendert LOOIJENGA, Riccardo FODDE. Cancer Stem Cells, Pluripotency, and Cellular Heterogeneity : A WNTer Perspective. Current Topics in Developmental Biology, 107 (2014) 373-404.

2014-01-08 [79] Sean M. CULLEN, Allison MAYLE, Lara ROSSI, Margaret A. GOODELL. Hematopoietic Stem Cell Development : An Epigenetic Journey. Current Topics in Developmental Biology, 107 (2014) 39-75.

2014-01-08 [80] Ana Mafalda Baptista TADEU, Valerie HORSLEY. Epithelial Stem Cells in Adult Skin. Current Topics in Developmental Biology, 107 (2014) 109-131.

2014-01-09 [81] Viviane TABAR, Lorenz STUDER. Pluripotent stem cells in regenerative medicine : challenges and recent progress. Nature Reviews Genetics, 15 (2014) 82-92.

2014-01-24 [82] Eliot MARSHALL. Historic Patent on Embryonic Stem Cells Faces Scrutiny. Science, 343 (2014) 359.

2014-02-12 [83] Anna FRENCH, Kim BURE, David A. BRINDLEY. An Assessment of the Key Barriers to the Commercialization and Clinical Adoption of Pluripotent Stem Cell Therapies. Rejuvenation Research, 17 (2014) 84-88.

2014-02-19 [84] Programme de Recherche Translationnelle en Santé (PRTS). Agence Nationale de la Recherche.

2014-02-24 [85] Stem cells. European Medicines Agency.

2014-02-24 [86] Summaries of scientific recommendations on classification of advanced-therapy medicinal products. European Medicines Agency.

2014-02-24 [87] Alexander van SERVELLEN, Ikuko OBA. Stem cell research : Trends in and perspectives on the evolving international landscape. Research Trends, 36 (2014) 6-10.

2014-03-03 [88] Barbara S. MALLON, Rebecca S. HAMILTON, Olga A. KOZHICH, Kory R. JOHNSON, Yang C. FANN, Mahendra S. RAO, Pamela G. ROBEY. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Research, 12 (2014) 376–386.

2014-03-07 [89] Progress Toward Therapies : Research We Fund. California’s Stem Cell Agency.

2014-03-25 [90] Significant Dates in U.S. Food and Drug Law History. Food and Drug Administration (FDA).

2014-04-01 [91] NIH Stem Cell Research Funding, FY 2002–2013. In Stem Cell Information. National Institutes of Health.

2014-04-05 [92] Hideyuki OKANO, Shinya YAMANAKA. iPS cell technologies : significance and applications to CNS regeneration and disease. Molecular Brain, 2014, 7:22

2014-04-16 [93] Pour un accès précoce aux médicaments. Organisation européenne pour les maladies rares (EURORDIS).

2014-04-21 [94] ARM Annual Industry Report – 2014. Alliance for Regenerative Medicine.

2014-05-01 [95] Insoo HYUN. Regulate embryos made for research. Nature, 509 (2014) 27-28.
2014-05-08 [96] Alison ABBOTT. Doubts over heart stem-cell therapy. Study queries early-phase trials of heart-disease treatment. Nature, 509 (2014) 15-16.

2014-05-25 [97] Query : Human Embryonic Stem Cell last5years[time]. gopubmed knowledge base. Transinsight GmbH.

2014-05-25 [98] Query : Induced Pluripotent Stem Cells[mesh] last5years[time]. gopubmed knowledge base. Transinsight GmbH.

2014-05-25 [99] Query : Stem Cells[mesh] last5years[time] "Bone Marrow"[mesh]. gopubmed knowledge base. Transinsight GmbH.

2014-05-25 [100] Query : Umbilical Cord[mesh] "Stem Cells"[mesh] last5years[time]. gopubmed knowledge base. Transinsight GmbH.

2014-05-25 [101] Query : Adult Stem Cells[mesh] Skin[mesh] -"Induced Pluripotent Stem Cells"[mesh] last5years[time]. gopubmed knowledge base. Transinsight GmbH.

2014-05-25 [102] Query : Mesenchymal Stromal Cells[mesh] last5years[time]. gopubmed knowledge base. Transinsight GmbH.

2014-05-27 [103] Query : Hematopoietic stem cell

2014-05-27 [104] Query : Mesenchymal stem cells

2014-05-27 [105] Query : Embryonic stem cells

2014-05-27 [106] Query : induced pluripotent stem cells

2014-05-28 [107] Initiative citoyenne européenne « Un de nous » : la Commission européenne publie sa réponse. Commission Européenne - IP/14/608.

2014-06 [108] Le grand dictionnaire terminologique.

2014-06 [109] NIH Human Embryonic Stem Cell Registry.

2014-06 [110] Mark HILL. UNSW Embryology. ISBN : 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G.

2014-06 [111] Clonage animal à des fins alimentaires. Ministère de l’agriculture.

2014-06 [112] FAQ about stem cells and regenerative medicine. EuroStemCell.

2014-06 [113] Les essais cliniques. Agence nationale de sécurité du médicament et des produits de santé (ANSM).

2014-06 [114] Glossaire relatif aux essais cliniques. Agence nationale de sécurité du médicament et des produits de santé (ANSM).

2014-06 [115] World Stem Policies. The Hinxton Group.

2014-06 [116] International Stem Cell Forum.

2014-06-05 [117] Erika Check HAYDEN. Funding windfall rescues abandoned stem-cell trial. Nature, 510 (2014) 18.

mardi 12 août 2014, par HUCHERY Mélissa